SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of senior vice president, chief financial officer, effective immediately. Ms. LaBrosse will succeed Elaine Sun, who is stepping down to pursue another opportunity. Ms. LaBrosse… Click here to view original post… […]
Tragically, almost 5 million people in the United States are evaluated in emergency departments for traumatic brain injury (TBI) each year. Over the past few decades, awareness of the magnitude and consequences of TBI has increased, particularly among athletes and military service members. Click here to view original post… […]
The successful candidate will support translational biomarker studies and in vitro and in vivo experiments supporting the Immunology portfolio.From Johnson & Johnson Family of Companies – Wed, 02 Feb 2022 20:07:55 GMT – View all […]
Remote work options may be considered on a case-by-case basis and if approved by the company. The Director, Clinical Project Scientist develops and drives the…From Johnson & Johnson Family of Companies – Wed, 02 Feb […]
Managing a team of field based Hematologic Malignancy Sales Specialists who will plan and execute territory business plans for breakthrough products in…From Johnson & Johnson Family of Companies – Wed, 02 Feb 2022 20:07:36 GMT […]
You are expected to work under a Sr. Scientist with limited supervision to develop new molecular tools, build strains and improve protein production in…From BASF – Wed, 02 Feb 2022 19:55:22 GMT – View all […]
SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Cortica Inc. ("Cortica"), a high-growth, technology-enabled healthcare company, announced today the appointment of two new executives to bring Cortica’s "whole-child" medical and behavioral care model to more families across the country. Kari O’Rourke, MSN, NP-C joins Cortica as Chief Operating Officer,… Click here to view original post… […]
Tragically, almost 5 million people in the United States are evaluated in emergency departments for traumatic brain injury (TBI) each year. Over the past few decades, awareness of the magnitude and consequences … […]
Data from a UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science study point to as much as a 27% increase in heart disease risk in postmenopausal women who experience both high levels of social isolation and loneliness. Click here to view original post… […]
Data from a UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science study point to as much as a 27% increase in heart disease risk in postmenopausal women who experience both high levels of social isol… […]
SAN DIEGO–(BUSINESS WIRE)–As the entrepreneurs behind Monarch Weather Consulting, meteorologists Crystal Egger and Kathryn Prociv create customized weather solution platforms that put real-time, actionable weather intelligence in their clients’ hands. A recent partnership announced with the Esri Startup Program will optimize Monarch’s ability to help clients from all industry sectors… Click here to view original post… […]
SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases with high unmet medical need, announced today that the Company and its collaborators Dr. Luc Furic, Head, Translational Prostate Cancer Research at Peter MacCallum… Click here to view original post… […]
SAN DIEGO–(BUSINESS WIRE)– #ASO–Argonaut to support n-Lorem’s expanding need for manufacturing of ASO therapeutics for nano-rare patients. Click here to view original post… […]
SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing novel small molecule therapeutics for the treatment of metabolic and inflammatory diseases, announced today the initiation of enrollment in three Phase 2 studies with the company’s lead drug ARD-101, a… Click here to view original post… […]
SAN DIEGO and CALGARY, AB: Independent safety review completed with no toxicity concerns Cohort builds on prior proof-of-concept data demonstrating clinical benefit of pelareorep-checkpoint inhibitor combination in pancreatic cancer Multi-indication trial being conducted in collaboration with Roche and AIO also includes cohorts in metastatic colorectal and advanced anal cancers SAN… Click here to view original post… […]
Plan and execute various laboratory activities with limited instruction to make detailed observations, plan, conduct, analyze, interpret, and report…From Illumina – Wed, 02 Feb 2022 00:12:17 GMT – View all San Diego, CA jobsClick here […]
Ideal candidate will have 1 or more years of prior hands-on accounts payable experience, preferably in the biotechnology or pharmaceutical industry.From Fate Therapeutics – Tue, 01 Feb 2022 20:14:53 GMT – View all San Diego, […]
The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will be professional rugby players. Click here to view original post… […]
The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will b… […]
CARLSBAD, Calif., and BRISBANE, Australia: CARLSBAD, Calif., and BRISBANE, Australia, Feb. 1, 2022 /PRNewswire/ — ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to maximize patient health, today announced publication of results from the PREVENT trial showing that fewer breast cancer… Click here to view original post… […]
SAN DIEGO–(BUSINESS WIRE)– #1536wells–Biosero is collaborating with Araceli Biosciences to use their Endeavor™ high-speed imaging platform in automated workflows run by Biosero’s software. Click here to view original post… […]
Copyright © 2022 Biotech Networks, LLC
